Equities

Willow Biosciences Inc

Willow Biosciences Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)0.09
  • Today's Change-0.005 / -5.26%
  • Shares traded98.10k
  • 1 Year change+20.00%
  • Beta1.1653
Data delayed at least 15 minutes, as of Nov 08 2024 20:43 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast

The one analyst offering a 12 month price target expects Willow Biosciences Inc share price to rise to 2.00 in the next year from the last price of 0.09.
High2,122.2%2.00
Med2,122.2%2.00
Low2,122.2%2.00

Earnings history & estimates in CAD

Willow Biosciences Inc reported annual 2020 losses of -0.34 per share on Mar 23, 2021.
Average growth rate+45.16%
More ▼

Revenue history & estimates in CAD

Willow Biosciences Inc. had 4th quarter 2020 revenues of 8.00k. The one analyst following the company did not expect it to generate revenues. The same period last year the company did not report revenues.
Average growth rate-100.00%
Willow Biosciences Inc. had revenues for the full year 2020 of 10.00k. This was 99.78% below the prior year's results.
Average growth rate-99.78%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.